Stay updated with breaking news from 80067710. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sangamo Therapeutics, Inc. (NASDAQ:SGMO – Get Free Report) has been assigned a consensus rating of “Hold” from the seven analysts that are currently covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell rating, three have given a hold rating and three have assigned a buy rating to the company. The […]
StockNews.com began coverage on shares of Sangamo Therapeutics (NASDAQ:SGMO – Free Report) in a research note released on Saturday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Other research analysts have also recently issued research reports about the company. Barclays decreased their target price on Sangamo Therapeutics from $11.00 to $9.00 […]
StockNews.com initiated coverage on shares of Sangamo Therapeutics (NASDAQ:SGMO – Free Report) in a report issued on Saturday. The firm issued a sell rating on the biopharmaceutical company’s stock. A number of other research analysts have also issued reports on the stock. Wells Fargo & Company restated an equal weight rating and set a $1.00 […]
Allspring Global Investments Holdings LLC grew its position in Sangamo Therapeutics, Inc. (NASDAQ:SGMO – Free Report) by 278.8% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 46,408 shares of the biopharmaceutical company’s stock after acquiring an additional 34,157 shares during the period. Allspring Global […]
Sangamo Therapeutics (NASDAQ:SGMO – Free Report) had its price objective trimmed by HC Wainwright from $5.00 to $3.00 in a research note published on Monday morning, Benzinga reports. The firm currently has a buy rating on the biopharmaceutical company’s stock. HC Wainwright also issued estimates for Sangamo Therapeutics’ Q4 2023 earnings at ($0.24) EPS, FY2023 […]